ARTBIO Therapeutics
ARTBIO Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
About ARTBIO Therapeutics
ARTBIO Therapeutics is a company founded in 2021 headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
ARTBIO Therapeutics is a clinical-stage radiopharmaceutical company focused on developing a new class of alpha radioligand therapies (ARTs) for cancer treatment. The company utilizes lead-212 (Pb212), an optimal alpha-emitting isotope, combined with tumor-specific targets to create highly targeted therapies designed to improve patient outcomes.
Explore ARTBIO Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.